Figure 1.
TNBC heterogeneity, showing TNBC subtype’s main histopathology, markers, and signalling pathways according to Lehmann et al. 2021 [19]. Created with BioRender.com, agreement number MS248V9M9Z.
TNBC heterogeneity, showing TNBC subtype’s main histopathology, markers, and signalling pathways according to Lehmann et al. 2021 [19]. Created with BioRender.com, agreement number MS248V9M9Z.